New York State Department of Health
New York State DOH Approves Castle Biosciences' Barrett’s Esophagus Test
The TissueCypher assay is designed to identify patients with Barrett's esophagus who are at risk of progressing to esophageal cancer.
NeoGenomics Wins New York State Approval for Solid Tumor, Lung Cancer NGS Tests
Although the approval is conditional, the company can now offer the tests for physicians and patients in the state.
Applied DNA Sciences to Launch PGx Testing Service in New York State
The company's clinical laboratory subsidiary's pharmacogenomic testing service, TR8 PGx, has been approved by the New York State Department of Health.
Myriad Genetics, Intermountain Precision Genomics Obtain NY Certification for Solid Tumor Testing
The NYS certification enables the companies to offer solid tumor testing through the Precise Oncology Solutions suite in all 50 states.
At ACMG, GUARDIAN Newborn Sequencing Study Reports High Uptake Rate
The researchers have already identified babies with G6PD deficiency who would have been missed by standard newborn screening.